CIMIT enables acceleration of fluorescent drug-screening device

Dec. 26, 2013
The Center for the Integration of Medicine and Innovative Technology (CIMIT) is helping to push Boston University (BU)'s PharmaCheck project—which is working to develop a fluorescent device for drug screening—to recognition.

The Center for the Integration of Medicine and Innovative Technology (CIMIT; Boston, MA) is helping to push Boston University (BU)'s PharmaCheck project—which is working to develop a fluorescent device for drug screening—to recognition. PharmaCheck, with the help of U.S. Pharmacopeia (USP; Rockville, MD) and the Saving Lives at Birth Consortium (Ottawa, ON, Canada), can detect counterfeit and sub-standard drugs for low-resource settings. In the coming months, the team will finalize initial product development and start field validation in Ghana with the Promoting the Quality of Medicines program of the USP Convention.

Counterfeit and substandard drug use represents an estimated $75 billion problem globally. Each year, millions of people are exposed to poor-quality medicines, contributing to over 100,000 preventable deaths. Under the direction of Dr. Muhammad Zaman, Biomedical Engineering associate professor at BU and the project's principal investigator, the PharmaCheck team developed a technology platform for a reliable, portable, low-cost system to detect sub-standard drugs. Proof-of-concept was shown in the lab, but the team recognized that help was needed to develop a viable, sustainable business plan.

Under the direction of Wolfgang Krull, a CIMIT Accelerator executive, the PharmaCheck project has completed a business plan, identified key product requirement specifications, selected a development vendor, and is completing the prototype that will be utilized for field testing.

-----

Follow us on Twitter, 'like' us on Facebook, and join our group on LinkedIn

Subscribe now to BioOptics World magazine; it's free!

About the Author

BioOptics World Editors

We edited the content of this article, which was contributed by outside sources, to fit our style and substance requirements. (Editor’s Note: BioOptics World has folded as a brand and is now part of Laser Focus World, effective in 2022.)

Sponsored Recommendations

Quantitative Microscopy with Deep Learning

Dec. 5, 2023
Explore the untapped potential of deep learning in video microscopy with our cutting-edge software, DeepTrack 2.2. Overcoming the steep learning curve, this innovative application...

Stimulated Brillouin scattering enhances CMOS chip for microwave signal processing

Dec. 5, 2023
University of Sydney Nano Institute researchers are pioneering photonic silicon chips and helping spur growth in Australia’s semiconductor industry.

Current Trends in Laser Absorption Spectroscopy: More than Just Beer's Law

Dec. 5, 2023
Dive into the cutting-edge world of absorption spectroscopy in our upcoming webinar, exploring groundbreaking techniques such as cavity ringdown spectroscopy, photoacoustic spectroscopy...

Insights on the Global Quantum Computing Market

Dec. 5, 2023
Dive into the cutting-edge realm of quantum computing with the Quantum Computing Market Forecast, a groundbreaking analysis by Hyperion Research, backed by the Quantum Economic...

Voice your opinion!

To join the conversation, and become an exclusive member of Laser Focus World, create an account today!